Tesamorelin

Description

Tesamorelin 2mg is a synthetic analog of human growth hormone-releasing hormone (GHRH), engineered to resist enzymatic degradation and extend biological activity. It binds to GHRH receptors in the anterior pituitary, stimulating the release of endogenous growth hormone (GH) and the subsequent rise of insulin-like growth factor 1 (IGF-1) levels.

Tesamorelin has been widely studied in models focused on visceral adiposity, metabolic syndrome, HIV-associated lipodystrophy, and age-related GH decline. Preclinical findings suggest it may help reduce abdominal fat, improve lipid profiles, and support regenerative pathways through enhanced GH signaling.

How Tesamorelin Works (Based on Preclinical Research):

• Stimulates GHRH receptors to promote natural GH secretion

• Increases circulating IGF-1 to support anabolic and lipolytic functions

• Reduces visceral adiposity through enhanced fat metabolism

• Avoids supraphysiologic GH spikes typical of exogenous GH

Potential Benefits (Based on Preclinical Research):

• Reduction of deep abdominal (visceral) fat

• Improved lipid profiles and insulin sensitivity

• Support for tissue repair, metabolism, and cellular recovery

• Useful in studies on aging, obesity, and GH deficiency models

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.